Share on LinkedInShare on LinkedIn

ARTICLE · 01 MAY 2020

PTAB Decision To Institute IPR Excluded From Trial

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

On June 23, 2014, Ivera Medical Corporation and Becton, Dickinson, and Company (plaintiffs) alleged infringement against Hospira, Inc. (defendant). Prior to trial, the parties exchanged motions in limine.

United StatesIntellectual Property

On June 23, 2014, Ivera Medical Corporation and Becton, Dickinson, and Company (plaintiffs) alleged infringement against Hospira, Inc. (defendant). Prior to trial, the parties exchanged motions in limine. In granting and denying in part the parties' motions, the court granted plaintiffs' motion in limine regarding inter partes review proceedings. Plaintiff's argued that defendant should not be allowed to submit evidence or argument regarding institution of the inter partes review of the asserted patent. Defendant opposed the motion arguing that the inter partes proceedings were part of the patent prosecution history and probative of the relevance of prior art.

In granting plaintiff's motion in limine, the court relied on the difference in standards – "a reasonable likelihood that the petitioner would prevail" contrasted with the "clear and convincing" standard. The court also noted that after the Patent Trial and Appeal Board (PTAB) instituted inter partes review,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from